Showing 1 - 10 of 654
US approves new Moderna Covid jab for over-65s
Published on 31/05/2025
» WASHINGTON - The US Food and Drug Administration has approved Moderna’s next-generation Covid-19 vaccine for everyone aged 65 and above, the company said on Saturday, the first endorsement since the regulator tightened requirements.
US drops some Covid vaccine recommendations
Published on 27/05/2025
» WASHINGTON - The US Centers for Disease Control and Prevention has stopped recommending routine Covid-19 vaccinations for pregnant women and healthy children, health regulators said on Tuesday.
New energy, tech fields poised for growth
Business, Nuntawun Polkuamdee, Published on 03/01/2025
» New energy, artificial intelligence (AI) technology and digital tokens are the top investment trends for 2025, according to initial coin offering (ICO) portal Kubix.
EU needs to focus on innovation
News, Published on 14/10/2024
» In the three decades after World War II, Western Europe caught up with the United States in terms of per capita GDP. But since the mid-1990s, this trend has reversed, with the US growing twice as fast as Europe.
Market disconnect
Oped, Postbag, Published on 22/05/2024
» Re: "Thailand has escaped recession: economic body", (Business, May 21).
Stats don't add up
Oped, Postbag, Published on 08/05/2024
» Re: "Astra jab blood clots 'rare' insists institute", (BP, May 4). One in 10 million in Thailand and one in 100,000 in the UK? How can the National Vaccine Institute possibly reconcile such a large sigma statistical anomaly and claim the risk of vaccine-induced blood clots is extremely rare in Thailand while it is criminally deadly in the UK? Worldwide, young people have been harmed and have died from blood clots -- a phenomenon that has never before been seen in these huge numbers.
WHO sees 'incredibly low' Covid, flu vaccination rates
Reuters, Published on 12/01/2024
» LONDON/CHICAGO - Low vaccination rates against the latest versions of coronavirus 2019 (Covid-19) and influenza are putting pressure on healthcare systems this winter, leading public health officials told Reuters.
A bargain in saving lives from malaria
News, Peter Singer, Published on 21/12/2023
» In 2021, malaria caused 619,000 deaths, 77% of which were children under five, and 96% of them in Africa. But now, after decades of research -- and several false dawns -- a malaria vaccine known as R21/Matrix-M (henceforth just R21) has been shown to be effective in 70-78% of cases. Although three doses are required before that level of protection is reached, and a booster is needed one year later, the vaccine, developed at the University of Oxford and the Serum Institute of India, is cheap. It can be produced for US$2-$4 (70-140 baht) per dose -- comparable to the cost of other childhood vaccines.
Katalin Kariko, scientific maverick who paved way for mRNA vaccines
AFP, Published on 02/10/2023
» WASHINGTON - Hungarian-born scientist Katalin Kariko's obsession with researching a substance called mRNA to fight disease once cost her a faculty position at a prestigious US university, which dismissed the idea as a dead end.
Nobel prize goes to mRNA Covid vaccine researchers
AFP, Published on 02/10/2023
» STOCKHOLM: Katalin Kariko and Drew Weissman won the Nobel Medicine Prize on Monday for work on messenger RNA (mRNA) technology that paved the way for groundbreaking Covid-19 vaccines.